Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_assertion description "[The increasing resistance of falciparum malaria to common antimalarial drugs has renewed interest in the compound proguanil normally metabolized to cycloguanil, a strong dihydrofolate reductase inhibitor, via the cytochrome P450 isozyme CYP2C19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_assertion evidence source_evidence_literature NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_assertion SIO_000772 10471063 NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_assertion wasDerivedFrom befree-20140225 NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_assertion wasGeneratedBy ECO_0000203 NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP684941.RAlk8QRxA_T-sDEFIL9mMVVUO85f38NcleG2I_GL_ycUs130_provenance.